Reactivity of IGF binding protein-3 isoforms towards concanavalin A in healthy adults and subjects with cirrhosis

Addiction Biology

Volumn 8, Issue 1, 2003, Pages 81-88

  Nedić, Olgica ^a,b   Nikolić, Judith Anna ^a   Prišić, Sladana ^a   Aćimovic, Jelena ^a   Hajduković Dragojlović, Ljiljana ^a  

^a Inst for the Appl of Nucl Energy   (Serbia)

^b Institute for the Application of Nuclear Energy   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CARBOHYDRATE; CONCANAVALIN A; GLYCOPROTEIN; LIGAND; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 3;

ALCOHOL LIVER CIRRHOSIS; ARTICLE; BLOTTING; CLINICAL ARTICLE; CONTROLLED STUDY; GLYCOSYLATION; HUMAN; ISOELECTRIC FOCUSING; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL;

EID: 0037360212     PISSN: 13556215     EISSN: None     Source Type: Journal    
DOI: 10.1080/1355621031000069927     Document Type: Article

References (27)

1. Stewart CEH, Rotwein P. Growth, differentiation and survival. Multiple physiological functions for insulin-like growth factors. Physiol Rev 1996;76:1005-26.
2. Drop SLS, Schuller AGP, Lindenbergh-Kortleve DJ, Groffen C, Bronkman A, Zwarthoff EC. Structural aspects of the IGFBP family. Growth Reg 1992;2:69-79.
3. Zimmermann EM, Li L, Hoyt EC, Pucilowska JB, Lichtman C, Lund PK. Cell-specific localization of insulin-like growth factor binding protein mRNAs in rat liver. Am J Physiol Gastrointest Liver Physiol 2000;278:G447-57.
4. Bond JJ, Meka S, Baxter RC. Binding characteristics of pro-insulin-like growth factor-II from cancer patients: binary and ternary complex formation with IGF binding protein-1 to -6. J Endocrinol 2000;165:253-60.
5. Collett-Solberg PF, Cohen P. The role of the insulin-like growth factor binding proteins and the IGFBP proteases in modulating IGF action. Endocrinol Metab Clin North Am 1996;25:591-614.
6. Firth SM, Baxter RC. Characterisation of recombinant glycosylation variants of insulin-like growth factor binding protein-3. J Endocrinol 1999;160:379-87.
7. Coverley JA, Martin JL, Baxter RC. The effect of phosphorylation by casein kinase-2 on the activity of insulin-like growth factor-binding protein-3. Endocrinology 2000;141:564-70.
8. Scharf J-G, Schmitz F, Frystyk J, et al. Insulin-like growth factor-I serum concentrations and patterns of insulin-like growth factor binding proteins in patients with chronic liver disease. J Hepatol 1996;25:689-99.
9. Nikolić JA, Todorović V, Božić M, et al. Serum insulin-like growth factor (IGF)-II is more closely associated with liver dysfunction than is IGF-I in patients with cirrhosis. Clin Chim Acta 2000;294:169-77.
10. Okan A, Gömleksi A, Akpinar K, Okan I, Yesil S, Tankurt E, Simsek I. Serum concentrations of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in patients with chronic hepatitis. Scand J Gastroenterol 2000;35:1212-15.
11. Nedić O, Nikolić JA, Hajduković-Dragojlović LJ, Todorović V, Masnikosa R. Alterations of IGF-binding proteins in patients with alcoholic liver cirrhosis. Alcohol 2000;21:223-9.
12. Liener IE, Sharon N, Goldstein IJ. The lectins. Academic Press, 1986; pp. 51-67.
13. Travis J, Bowen J, Tewksbury D, Johnson D, Pannell R. Isolation of albumin from whole human plasma and fractionation of albumin-depleted plasma. Biochem J 1976;157:301-6.
14. Nikolić JA, Nedić O, Gavrović M, Stojanović D, Živković B. Different serum insulin-like growth factor-I (IGF-I) binding characteristics accompany reduced growth associated with low thyroid hormone and/or low total IGF-I status in young pigs. Acta Vet Beograd 1998;48:3-18.
15. Nikolić JA, Nedić O, Masnikosa R. Determination of insulin-like growth factor-II in human serum. J Serb Chem Soc 1998;63:805-15.
16. Hossenlopp P, Seurin D, Segovia-Quinson B, Hardouin S, Binoux M. Analysis of serum insulin-like growth factor-binding proteins using Western blotting: use of the method for titration of the binding proteins and competitive binding studies. Anal Chem 1986;154:138-43.
17. Weber MM, Spöttl G, Gössl C, Engelhardt D. Characterization of human insulin-like growth factor-binding proteins by two-dimensional polyacrylamide gel electrophoresis and Western ligand blot analysis. J Clin Endocrinol Metab 1999;84:1679-84.
18. Martin JL, Baxter RC. Insulin-like growth factor binding protein from human plasma. Purification and characterization. J Biol Chem 1986;261:8754-60.
19. Diamandi A, Mistry J, Krishna RG, Khosravi J. Immunoassay of insulin-like growth factor-binding protein-3 (IGFBP-3): new means to quantifying IGFBP-3 proteolysis. J Clin Endocrinol Metab 2000;85:2327-33.
20. Stibler H, Borg S. Glycoprotein glycosyltransferase activities in serum in alcohol-abusing patients and healthy controls. Scand J Clin Lab Invest 1991;51:43-51.
21. Inoue T, Yamauchi M, Toda G, Ohkawa K. Microheterogeneity with concanavalin A affinity of serum transferrin in patients with alcoholic liver disease. Alcohol Clin Exp Res 1996;20:363A-5.
22. Firth SM, Ganeshprasad U, Baxter RC. Structural determinants of ligand and cell surface binding of insulin-like growth factor binding protein-3. J Biol Chem 1998;273:2631-8.
23. Scharf J-G, Braulke T, Hartmann H, Ramadori R. Regulation of the components of the 150 kDa IGF binding protein complex in cocultures of rat hepatocytes and Kupffer cells by 3′,5′-cyclic adenosine monophosphate. J Cell Phys 2001;186:425-36.
24. Booth BA, Boes M, Bar RS. IGFBP-3 proteolysis by plasmin, thrombin, serum: heparin binding, IGF binding, and structure of fragments. Endocrinol Metab 1996;34:E465-70.
25. Gibson TLB, Cohen P. Inflammation-related neutrophil proteases, cathepsin G and elastase, function as insulin-like growth factor binding protein proteases. Growth Horm IGF Res 1999;9:241-53.
26. Ottesen LH, Bendtsen F, Flyvbjerg A. The insulin like growth factor binding protein 3 ternary complex is reduced in cirrhosis. Liver 2001;21:350-6.
27. Gong YW, Cui L, Minuk GY. The expression of insulin-like growth factor binding proteins in human hepatocellular carcinoma. Mol Cell Biochem 2000;207:101-4.